Most lately, it's been discovered that conolidine and the above mentioned derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in identical regions as classical opioid receptors, it binds to a wide array of endogenous opioids. Compared with most opioid receptors, this receptor functions to be a scavenger https://erwinf329zcd0.atualblog.com/profile